Bright Minds Biosciences Inc (DRUG)

Bright Minds Biosciences Inc (DRUG) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $506M; returns 1 day -0.4%, 1 week +2.3%, 1 year -14.7%.

Bright Minds Biosciences Inc. (DRUG) is a clinical-stage biopharmaceutical company focused on developing novel small-molecule therapeutics for neurological and neurodevelopmental disorders. The company's core business model revolves around the research and development of drug candidates, funded primarily through capital raises, as it does not yet have commercialized products generating revenue.

Groups DRUG belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Pharmaceuticals
• Clinical Stage
• Neuroscience
• Neurological Disorders
• Epilepsy
• Healthcare
• CNS Disorders
• Rare Diseases
• Drug Discovery
• Prader-Willi Syndrome
• Unmet Medical Needs

DRUG financial model: income statement, cash flow and balance sheet